With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Role of Myosin VI in Pediatric Glioma Proliferation and Invasion||University of Pennsylvania / Monalisa Mukherjea||Young Investigator Grants||2012||Pennsylvania|
|Investigation of Pediatric Rhabdomyosarcoma Recurrence through Single-Cell Sequencing||St. Jude Children's Research Hospital / Anand Patel, MD/PhD||Young Investigator Grants||2019||Tennessee|
|Molecular Basis of ALK Inhibition Resistance in High-risk Neuroblastoma||Dana-Farber Cancer Institute / David Debruyne, PhD||Young Investigator Grants||2016||Massachusetts|
|Zebrafish Modeling of PAX3-FOXO1 Driven Rhabdomyosarcoma||University of Texas Southwestern Medical Center / Genevieve Kendall, PhD||Young Investigator Grants||2015||Texas|
|End-of-Life Care of Children with Cancer: Variation and Stakeholder Priorities||University of Alabama at Birmingham / Emily Johnston, MD||Young Investigator Grants||2017||Alabama|
|Autophagy and mTOR Inhibition in Pediatric Gliomas with BRAF Mutations||University of Colorado Denver / Jean Mulcahy Levy, MD||Young Investigator Grants||2014||Colorado|
|Effect of SLCO Polymorphisms on High-Dose Methotrexate Clearance in Pediatric Oncology Patients||Vanderbilt University Medical Center / Rachael Schulte, MD||Young Investigator Grants||2018||Tennessee|
|Screening for New Rhabdomyosaroma Pathogenesis Genes in a Drosophila Model||University of Texas Southwestern Medical Center / Kathleen Galindo||Young Investigator Grants||2012||Texas|
|Assess the activity of ABT-737 as a single agent against neuroblastoma cell lines grown in cell culture||Children's Hospital Los Angeles / Theresa Harned, MD||Young Investigator Grants||2006||California|
|PRL3 as a Novel Therapeutic Target for Relapsed T-cell Acute Lymphoblastic Leukemia||Massachusetts General Hospital / Jessica Blackburn, PhD||Young Investigator Grants||2013||Massachusetts|